Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 743

1.

Type D Personality, Concomitant Depressive and Anxiety Disorders, and Treatment Outcomes in Somatic Symptom and Related Disorders: An Observational Longitudinal Cohort Study.

de Vroege L, de Heer EW, van der Thiel E, van den Broek KC, van Eck van der Sluijs JF, van der Feltz-Cornelis CM.

Front Psychiatry. 2019 Jun 19;10:417. doi: 10.3389/fpsyt.2019.00417. eCollection 2019.

2.

Relationship Between Treatment Initiation and Healthcare Costs in Alzheimer's Disease.

Black CM, Lipton RB, Thiel E, Brouillette M, Khandker R.

J Alzheimers Dis. 2019;68(4):1575-1585. doi: 10.3233/JAD-180983.

PMID:
30909221
3.

Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study.

Llanos JP, Bell CF, Packnett E, Thiel E, Irwin DE, Hahn B, Ortega H.

J Asthma Allergy. 2019 Jan 25;12:43-58. doi: 10.2147/JAA.S189676. eCollection 2019.

4.

Focus-Induced Photoresponse: a novel way to measure distances with photodetectors.

Pekkola O, Lungenschmied C, Fejes P, Handreck A, Hermes W, Irle S, Lennartz C, Schildknecht C, Schillen P, Schindler P, Send R, Valouch S, Thiel E, Bruder I.

Sci Rep. 2018 Jun 15;8(1):9208. doi: 10.1038/s41598-018-27475-1.

5.

Women with Newly Diagnosed Uterine Fibroids: Treatment Patterns and Cost Comparison for Select Treatment Options.

Bonafede MM, Pohlman SK, Miller JD, Thiel E, Troeger KA, Miller CE.

Popul Health Manag. 2018 Mar;21(S1):S13-S20. doi: 10.1089/pop.2017.0151.

PMID:
29649369
6.

Variation in length of hospital stay after lung cancer surgery in the Netherlands.

von Meyenfeldt EM, Marres GMH, van Thiel E, Damhuis RAM.

Eur J Cardiothorac Surg. 2018 Sep 1;54(3):560-564. doi: 10.1093/ejcts/ezy074.

PMID:
29514197
7.

Documentation of Crucial Information Relating to Critically Ill Patients.

Bear A, Thiel E.

J Palliat Care. 2018 Jan;33(1):5-8. doi: 10.1177/0825859717746273. Epub 2017 Dec 20.

PMID:
29260613
8.

Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: a CIBMTR retrospective analysis.

Malogolowkin MH, Hemmer MT, Le-Rademacher J, Hale GA, Mehta PA, Smith AR, Kitko C, Abraham A, Abdel-Azim H, Dandoy C, Angel Diaz M, Gale RP, Guilcher G, Hayashi R, Jodele S, Kasow KA, MacMillian ML, Thakar M, Wirk BM, Woolfrey A, Thiel EL.

Bone Marrow Transplant. 2017 Nov;52(11):1549-1555. doi: 10.1038/bmt.2017.178. Epub 2017 Sep 4.

9.

Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.

Kobitzsch B, Gökbuget N, Schwartz S, Reinhardt R, Brüggemann M, Viardot A, Wäsch R, Starck M, Thiel E, Hoelzer D, Burmeister T.

Haematologica. 2017 Oct;102(10):1739-1747. doi: 10.3324/haematol.2016.161273. Epub 2017 Jul 27.

10.
11.

Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation.

Bitan M, Ahn KW, Millard HR, Pulsipher MA, Abdel-Azim H, Auletta JJ, Brown V, Chan KW, Diaz MA, Dietz A, Vincent MG, Guilcher G, Hale GA, Hayashi RJ, Keating A, Mehta P, Myers K, Page K, Prestidge T, Shah NN, Smith AR, Woolfrey A, Thiel E, Davies SM, Eapen M.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1523-1530. doi: 10.1016/j.bbmt.2017.05.011. Epub 2017 May 17.

12.

Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.

Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ, Boulad F, Brown VI, Camitta BM, Chan KW, Chaudhury S, Cowan MJ, Angel-Diaz M, Gadalla SM, Gale RP, Hale G, Kasow KA, Keating AK, Kitko CL, MacMillan ML, Olsson RF, Page KM, Seber A, Smith AR, Warwick AB, Wirk B, Mehta PA.

Biol Blood Marrow Transplant. 2017 Aug;23(8):1342-1349. doi: 10.1016/j.bbmt.2017.04.018. Epub 2017 Apr 24.

13.

Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial.

Herrlinger U, Schäfer N, Fimmers R, Griesinger F, Rauch M, Kirchen H, Roth P, Glas M, Bamberg M, Martus P, Thiel E, Korfel A, Weller M.

J Cancer Res Clin Oncol. 2017 Sep;143(9):1815-1821. doi: 10.1007/s00432-017-2423-5. Epub 2017 Apr 22.

14.

Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet!

Korfel A, Chamberlain M, Neuwelt E, Thiel E, Doolittle N, Schlegel U, Dreyling M, Rubenstein J, Fischer L, Björkholm M, Martus P, Weller M, Glantz M.

J Clin Oncol. 2016 May 20;34(15):1829-30. doi: 10.1200/JCO.2015.65.0879. Epub 2016 Mar 21. No abstract available.

15.

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.

Korfel A, Schlegel U, Herrlinger U, Dreyling M, Schmidt C, von Baumgarten L, Pezzutto A, Grobosch T, Kebir S, Thiel E, Martus P, Kiewe P.

J Clin Oncol. 2016 May 20;34(15):1757-63. doi: 10.1200/JCO.2015.64.9897. Epub 2016 Mar 14.

PMID:
26976424
16.

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.

Krug U, Berdel WE, Gale RP, Haferlach C, Schnittger S, Müller-Tidow C, Braess J, Spiekermann K, Staib P, Beelen D, Serve H, Schliemann C, Stelljes M, Balleisen L, Maschmeyer G, Grüneisen A, Eimermacher H, Giagounidis A, Rasche H, Hehlmann R, Lengfelder E, Thiel E, Reichle A, Aul C, Ludwig WD, Kern W, Haferlach T, Köpcke W, Görlich D, Sauerland MC, Heinecke A, Wörmann BJ, Hiddemann W, Büchner T.

Leukemia. 2016 Jun;30(6):1230-6. doi: 10.1038/leu.2016.25. Epub 2016 Feb 9.

PMID:
26859081
17.

Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

Burke MJ, Verneris MR, Le Rademacher J, He W, Abdel-Azim H, Abraham AA, Auletta JJ, Ayas M, Brown VI, Cairo MS, Chan KW, Diaz Perez MA, Dvorak CC, Egeler RM, Eldjerou L, Frangoul H, Guilcher GMT, Hayashi RJ, Ibrahim A, Kasow KA, Leung WH, Olsson RF, Pulsipher MA, Shah N, Shah NN, Thiel E, Talano JA, Kitko CL.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2154-2159. doi: 10.1016/j.bbmt.2015.08.023. Epub 2015 Aug 29.

18.

Motives underlying food consumption in the Western Balkans: consumers' profiles and public health strategies.

Mardon J, Thiel E, Laniau M, Sijtsema S, Zimmermann K, Barjolle D.

Int J Public Health. 2015 Jul;60(5):517-26. doi: 10.1007/s00038-015-0684-9. Epub 2015 May 27.

PMID:
26012846
19.

Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.

Kreher S, Jöhrens K, Strehlow F, Martus P, Borowiec K, Radke J, Heppner F, Roth P, Thiel E, Pietsch T, Weller M, Korfel A.

Neuro Oncol. 2015 Jul;17(7):1016-21. doi: 10.1093/neuonc/nov046. Epub 2015 Mar 26.

20.

Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.

Korfel A, Thiel E, Martus P, Möhle R, Griesinger F, Rauch M, Röth A, Hertenstein B, Fischer T, Hundsberger T, Mergenthaler HG, Junghanß C, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Roth P, Bamberg M, Pietsch T, Weller M.

Neurology. 2015 Mar 24;84(12):1242-8. doi: 10.1212/WNL.0000000000001395. Epub 2015 Feb 25.

21.

Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.

Roth P, Keller A, Hoheisel JD, Codo P, Bauer AS, Backes C, Leidinger P, Meese E, Thiel E, Korfel A, Weller M.

Eur J Cancer. 2015 Feb;51(3):382-90. doi: 10.1016/j.ejca.2014.10.028. Epub 2014 Dec 17.

22.

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.

Hoelzer D, Walewski J, Döhner H, Viardot A, Hiddemann W, Spiekermann K, Serve H, Dührsen U, Hüttmann A, Thiel E, Dengler J, Kneba M, Schaich M, Schmidt-Wolf IG, Beck J, Hertenstein B, Reichle A, Domanska-Czyz K, Fietkau R, Horst HA, Rieder H, Schwartz S, Burmeister T, Gökbuget N; German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia.

Blood. 2014 Dec 18;124(26):3870-9. doi: 10.1182/blood-2014-03-563627. Epub 2014 Oct 30.

23.

Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial.

Kreher S, Strehlow F, Martus P, Roth P, Hertenstein B, Röth A, Birnbaum T, Griesinger F, Rauch M, Kanz L, Thiel E, Weller M, Korfel A.

Ann Hematol. 2015 Mar;94(3):409-14. doi: 10.1007/s00277-014-2212-z. Epub 2014 Sep 13.

24.

Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation.

Reinwald M, Schleyer E, Kiewe P, Blau IW, Burmeister T, Pursche S, Neumann M, Notter M, Thiel E, Hofmann WK, Kolb HJ, Burdach S, Bender HU.

Biomed Res Int. 2014;2014:637059. doi: 10.1155/2014/637059. Epub 2014 Jun 15.

25.

A cross-cultural segmentation of western Balkan consumers: focus on preferences toward traditional fresh cow cheese.

Giraud G, Amblard C, Thiel E, Zaouche-Laniau M, Stojanović Z, Pohar J, Butigan R, Cvetković M, Mugosa B, Kendrovski V, Mora C, Barjolle D.

J Sci Food Agric. 2013 Nov;93(14):3464-72. doi: 10.1002/jsfa.6350. Epub 2013 Sep 19.

PMID:
23963819
26.

Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma.

Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, Kiewe P.

Radiol Oncol. 2013 May 21;47(2):103-10. doi: 10.2478/raon-2013-0016. Print 2013 Jun.

27.

A methodological approach for deriving regional crop rotations as basis for the assessment of the impact of agricultural strategies using soil erosion as example.

Lorenz M, Fürst C, Thiel E.

J Environ Manage. 2013 Sep;127 Suppl:S37-47. doi: 10.1016/j.jenvman.2013.04.050. Epub 2013 Jun 7.

PMID:
23751946
28.

Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma.

Burmeister T, Molkentin M, Schwartz S, Gökbuget N, Hoelzer D, Thiel E, Reinhardt R.

Mol Oncol. 2013 Aug;7(4):850-8. doi: 10.1016/j.molonc.2013.04.006. Epub 2013 Apr 25.

29.

Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization.

Heesch S, Neumann M, Schwartz S, Bartram I, Schlee C, Burmeister T, Hänel M, Ganser A, Heuser M, Wendtner CM, Berdel WE, Gökbuget N, Hoelzer D, Hofmann WK, Thiel E, Baldus CD.

Ann Hematol. 2013 Jun;92(6):747-58. doi: 10.1007/s00277-013-1694-4. Epub 2013 Feb 15.

PMID:
23412561
30.

FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.

Neumann M, Coskun E, Fransecky L, Mochmann LH, Bartram I, Sartangi NF, Heesch S, Gökbuget N, Schwartz S, Brandts C, Schlee C, Haas R, Dührsen U, Griesshammer M, Döhner H, Ehninger G, Burmeister T, Blau O, Thiel E, Hoelzer D, Hofmann WK, Baldus CD.

PLoS One. 2013;8(1):e53190. doi: 10.1371/journal.pone.0053190. Epub 2013 Jan 24.

31.

Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas.

Korfel A, Elter T, Thiel E, Hänel M, Möhle R, Schroers R, Reiser M, Dreyling M, Eucker J, Scholz C, Metzner B, Röth A, Birkmann J, Schlegel U, Martus P, Illerhaus G, Fischer L.

Haematologica. 2013 Mar;98(3):364-70. doi: 10.3324/haematol.2012.077917. Epub 2012 Dec 14.

32.

Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia.

Tracey J, Zhang MJ, Thiel E, Sobocinski KA, Eapen M.

Biol Blood Marrow Transplant. 2013 Feb;19(2):255-9. doi: 10.1016/j.bbmt.2012.09.019. Epub 2012 Oct 3.

33.

Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseases.

Hilgendorf I, Wolff D, Nogai A, Kundt G, Hahn J, Holler E, Uharek L, Junghanss C, Leithäuser M, Thiel E, Freund M, Kahl C.

Onkologie. 2012;35(9):487-92. Epub 2012 Aug 13.

PMID:
23007145
34.

Surgery for primary CNS lymphoma? Challenging a paradigm.

Weller M, Martus P, Roth P, Thiel E, Korfel A; German PCNSL Study Group.

Neuro Oncol. 2012 Dec;14(12):1481-4. doi: 10.1093/neuonc/nos159. Epub 2012 Sep 14.

35.

Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.

Roth P, Martus P, Kiewe P, Möhle R, Klasen H, Rauch M, Röth A, Kaun S, Thiel E, Korfel A, Weller M.

Neurology. 2012 Aug 28;79(9):890-6. doi: 10.1212/WNL.0b013e318266fcb2. Epub 2012 Aug 15.

PMID:
22895585
36.

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Neumann M, Heesch S, Gökbuget N, Schwartz S, Schlee C, Benlasfer O, Farhadi-Sartangi N, Thibaut J, Burmeister T, Hoelzer D, Hofmann WK, Thiel E, Baldus CD.

Blood Cancer J. 2012 Jan;2(1):e55. doi: 10.1038/bcj.2011.49. Epub 2012 Jan 27.

37.

Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia.

Kaiser M, Kühnl A, Reins J, Fischer S, Ortiz-Tanchez J, Schlee C, Mochmann LH, Heesch S, Benlasfer O, Hofmann WK, Thiel E, Baldus CD.

Blood Cancer J. 2011 Jul;1(7):e28. doi: 10.1038/bcj.2011.28. Epub 2011 Jul 15.

38.

Rabbit antithymocyte globulin (thymoglobulin) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.

Na IK, Wittenbecher F, Dziubianau M, Herholz A, Mensen A, Kunkel D, Blau O, Blau I, Thiel E, Uharek L, Scheibenbogen C, Rieger K, Thiel A.

Haematologica. 2013 Jan;98(1):23-30. doi: 10.3324/haematol.2012.067611. Epub 2012 Jul 16.

39.

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

Gökbuget N, Kneba M, Raff T, Trautmann H, Bartram CR, Arnold R, Fietkau R, Freund M, Ganser A, Ludwig WD, Maschmeyer G, Rieder H, Schwartz S, Serve H, Thiel E, Brüggemann M, Hoelzer D; German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia.

Blood. 2012 Aug 30;120(9):1868-76. Epub 2012 Mar 22.

PMID:
22442346
40.

Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.

Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1204-10. doi: 10.1016/j.bbmt.2012.01.007. Epub 2012 Mar 6. Erratum in: Biol Blood Marrow Transplant. 2012 Sep;18(9):1466. Thiel, Elizabeth L [added].

41.

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.

Korfel A, Weller M, Martus P, Roth P, Klasen HA, Roeth A, Rauch M, Hertenstein B, Fischer T, Hundsberger T, Leithäuser M, Birnbaum T, Kirchen H, Mergenthaler HG, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Fischer L.

Ann Oncol. 2012 Sep;23(9):2374-80. doi: 10.1093/annonc/mdr627. Epub 2012 Mar 5.

42.

Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines.

Frenzel K, Ganepola S, Michel D, Thiel E, Krüger DH, Uharek L, Hofmann J.

Med Microbiol Immunol. 2012 Aug;201(3):277-86. doi: 10.1007/s00430-012-0229-2.

PMID:
22297735
43.

High-power solid-state cw dye laser.

Bornemann R, Thiel E, Bolívar PH.

Opt Express. 2011 Dec 19;19(27):26382-93. doi: 10.1364/OE.19.026382.

PMID:
22274222
44.

Molecular analysis of the t(2;8)/MYC-IGK translocation in high-grade lymphoma/leukemia by long-distance inverse PCR.

Kroenlein H, Schwartz S, Reinhardt R, Rieder H, Molkentin M, Gökbuget N, Hoelzer D, Thiel E, Burmeister T.

Genes Chromosomes Cancer. 2012 Mar;51(3):290-9. doi: 10.1002/gcc.21915. Epub 2011 Nov 25.

PMID:
22120970
45.

Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.

Kühnl A, Gökbuget N, Kaiser M, Schlee C, Stroux A, Burmeister T, Mochmann LH, Hoelzer D, Hofmann WK, Thiel E, Baldus CD.

Blood. 2011 Dec 8;118(24):6362-7. doi: 10.1182/blood-2011-04-350850. Epub 2011 Oct 18.

PMID:
22010100
46.

Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.

Hopfer O, Nolte F, Mossner M, Komor M, Kmetsch A, Benslasfer O, Reissmann M, Nowak D, Hoelzer D, Thiel E, Hofmann WK.

Eur J Haematol. 2012 Feb;88(2):144-53. doi: 10.1111/j.1600-0609.2011.01715.x. Epub 2011 Nov 22.

PMID:
21967505
47.

Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts.

Blau O, Baldus CD, Hofmann WK, Thiel G, Nolte F, Burmeister T, Türkmen S, Benlasfer O, Schümann E, Sindram A, Molkentin M, Mundlos S, Keilholz U, Thiel E, Blau IW.

Blood. 2011 Nov 17;118(20):5583-92. doi: 10.1182/blood-2011-03-343467. Epub 2011 Sep 23.

48.

Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.

Burmeister T, Gröger D, Kühn A, Hoelzer D, Thiel E, Reinhardt R.

DNA Repair (Amst). 2011 Nov 10;10(11):1131-7. doi: 10.1016/j.dnarep.2011.08.010. Epub 2011 Sep 22.

PMID:
21944569
49.

High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia.

Kühnl A, Kaiser M, Neumann M, Fransecky L, Heesch S, Radmacher M, Marcucci G, Bloomfield CD, Hofmann WK, Thiel E, Baldus CD.

Leuk Res. 2011 Dec;35(12):1585-90. doi: 10.1016/j.leukres.2011.08.006. Epub 2011 Sep 6.

50.

Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.

Fischer L, Hummel M, Korfel A, Lenze D, Joehrens K, Thiel E.

Neuro Oncol. 2011 Oct;13(10):1090-8. doi: 10.1093/neuonc/nor107. Epub 2011 Jul 29.

Supplemental Content

Support Center